# Power Solutions International, Inc.: financial statements, quarterly

PSIX · Nasdaq · CIK 1137091 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/psix.md) · [Financials](/companies/psix/financials.md) · [Filings](/companies/psix/filings.md) · [Insiders](/companies/psix/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/psix/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [116](/filings/0001137091-24-000027.md) | [105 d](/filings/0001137091-25-000005.md) | [95.2](/filings/0001137091-25-000010.md) | [111](/filings/0001137091-25-000016.md) | [126](/filings/0001628280-25-050177.md) | [144 d](/filings/0001628280-26-013207.md) | [135](/filings/0001628280-26-033451.md) | [192](/filings/0001628280-26-054328.md) | [204](/filings/0001628280-25-050177.md) | [191 d](/filings/0001628280-26-013207.md) | [129](/filings/0001628280-26-033451.md) | [153](/filings/0001628280-26-054328.md) |
| Cost of revenue | $m | [88.0](/filings/0001137091-24-000027.md) | [77.2 d](/filings/0001137091-25-000005.md) | [69.5](/filings/0001137091-25-000010.md) | [75.4](/filings/0001137091-25-000016.md) | [89.4](/filings/0001628280-25-050177.md) | [101 d](/filings/0001628280-26-013207.md) | [95.2](/filings/0001628280-26-033451.md) | [138](/filings/0001628280-26-054328.md) | [155](/filings/0001628280-25-050177.md) | [149 d](/filings/0001628280-26-013207.md) | [99.2](/filings/0001628280-26-033451.md) | [111](/filings/0001628280-26-054328.md) |
| Gross profit | $m | [27.9](/filings/0001137091-24-000027.md) | [27.5 d](/filings/0001137091-25-000005.md) | [25.8](/filings/0001137091-25-000010.md) | [35.2](/filings/0001137091-25-000016.md) | [36.4](/filings/0001628280-25-050177.md) | [43.2 d](/filings/0001628280-26-013207.md) | [40.3](/filings/0001628280-26-033451.md) | [54.1](/filings/0001628280-26-054328.md) | [48.7](/filings/0001628280-25-050177.md) | [41.8 d](/filings/0001628280-26-013207.md) | [29.4](/filings/0001628280-26-033451.md) | [41.4](/filings/0001628280-26-054328.md) |
| Research and development | $m | [4.8](/filings/0001137091-24-000027.md) | [5.4 d](/filings/0001137091-25-000005.md) | [5.2](/filings/0001137091-25-000010.md) | [5.0](/filings/0001137091-25-000016.md) | [4.7](/filings/0001628280-25-050177.md) | [5.2 d](/filings/0001628280-26-013207.md) | [4.2](/filings/0001628280-26-033451.md) | [4.6](/filings/0001628280-26-054328.md) | [4.8](/filings/0001628280-25-050177.md) | [4.5 d](/filings/0001628280-26-013207.md) | [4.8](/filings/0001628280-26-033451.md) | [5.1](/filings/0001628280-26-054328.md) |
| Selling, general and administrative | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | [16.7](/filings/0001628280-26-054328.md) | not reported | not reported | not reported | [12.1](/filings/0001628280-26-054328.md) |
| Operating income | $m | [12.1](/filings/0001137091-24-000027.md) | [12.3 d](/filings/0001137091-25-000005.md) | [10.7](/filings/0001137091-25-000010.md) | [25.3](/filings/0001137091-25-000016.md) | [20.5](/filings/0001628280-25-050177.md) | [25.2 d](/filings/0001628280-26-013207.md) | [24.6](/filings/0001628280-26-033451.md) | [32.5](/filings/0001628280-26-054328.md) | [28.4](/filings/0001628280-25-050177.md) | [24.2 d](/filings/0001628280-26-013207.md) | [11.4](/filings/0001628280-26-033451.md) | [23.9](/filings/0001628280-26-054328.md) |
| Interest expense | $m | [4.2](/filings/0001137091-23-000017.md) | [3.6 d](/filings/0001137091-24-000007.md) | [3.3](/filings/0001137091-24-000014.md) | [2.9](/filings/0001137091-25-000016.md) | [2.8](/filings/0001628280-25-050177.md) | [2.4 d](/filings/0001628280-26-013207.md) | [1.8](/filings/0001628280-26-033451.md) | [1.7](/filings/0001628280-26-054328.md) | [1.6](/filings/0001628280-25-050177.md) | [1.6 d](/filings/0001628280-26-013207.md) | [1.7](/filings/0001628280-26-033451.md) | [1.6](/filings/0001628280-26-054328.md) |
| Income tax | $m | [0.2](/filings/0001137091-24-000027.md) | [0.4 d](/filings/0001137091-25-000005.md) | [0.2](/filings/0001137091-25-000010.md) | [0.9](/filings/0001137091-25-000016.md) | [0.3](/filings/0001628280-25-050177.md) | [(0.5) d](/filings/0001628280-26-013207.md) | [3.8](/filings/0001628280-26-033451.md) | [(20.1)](/filings/0001628280-26-054328.md) | [(0.9)](/filings/0001628280-25-050177.md) | [6.6 d](/filings/0001628280-26-013207.md) | [2.4](/filings/0001628280-26-033451.md) | [5.6](/filings/0001628280-26-054328.md) |
| Net income | $m | [7.8](/filings/0001137091-24-000027.md) | [8.4 d](/filings/0001137091-25-000005.md) | [7.1](/filings/0001137091-25-000010.md) | [21.5](/filings/0001137091-25-000016.md) | [17.3](/filings/0001628280-25-050177.md) | [23.3 d](/filings/0001628280-26-013207.md) | [19.1](/filings/0001628280-26-033451.md) | [51.2](/filings/0001628280-26-054328.md) | [27.6](/filings/0001628280-25-050177.md) | [16.1 d](/filings/0001628280-26-013207.md) | [7.3](/filings/0001628280-26-033451.md) | [16.9](/filings/0001628280-26-054328.md) |
| Diluted EPS | $ per share | [0.34](/filings/0001137091-24-000027.md) | not reported | [0.31](/filings/0001137091-25-000010.md) | [0.94](/filings/0001137091-25-000016.md) | [0.75](/filings/0001628280-25-050177.md) | not reported | [0.83](/filings/0001628280-26-033451.md) | [2.22](/filings/0001628280-26-054328.md) | [1.20](/filings/0001628280-25-050177.md) | not reported | [0.32](/filings/0001628280-26-033451.md) | [0.73](/filings/0001628280-26-054328.md) |
| Basic EPS | $ per share | [0.34](/filings/0001137091-24-000027.md) | not reported | [0.31](/filings/0001137091-25-000010.md) | [0.94](/filings/0001137091-25-000016.md) | [0.75](/filings/0001628280-25-050177.md) | not reported | [0.83](/filings/0001628280-26-033451.md) | [2.23](/filings/0001628280-26-054328.md) | [1.20](/filings/0001628280-25-050177.md) | not reported | [0.32](/filings/0001628280-26-033451.md) | [0.73](/filings/0001628280-26-054328.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Gross profit: us-gaap:GrossProfit
- Research and development: us-gaap:ResearchAndDevelopmentExpense
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [31.8](/filings/0001137091-24-000027.md) | [22.8](/filings/0001137091-25-000005.md) | [33.1](/filings/0001137091-25-000010.md) | [28.8](/filings/0001137091-25-000016.md) | [40.5](/filings/0001628280-25-050177.md) | [55.3](/filings/0001628280-26-013207.md) | [50.0](/filings/0001628280-26-033451.md) | [49.5](/filings/0001628280-26-054328.md) | [49.0](/filings/0001628280-25-050177.md) | [41.3](/filings/0001628280-26-054328.md) | [45.1](/filings/0001628280-26-033451.md) | [70.1](/filings/0001628280-26-054328.md) |
| Current assets | $m | [226](/filings/0001137091-23-000017.md) | [205](/filings/0001137091-25-000005.md) | [209](/filings/0001137091-24-000014.md) | [232](/filings/0001137091-24-000020.md) | [265](/filings/0001137091-24-000027.md) | [254](/filings/0001628280-26-013207.md) | [278](/filings/0001137091-25-000010.md) | [310](/filings/0001137091-25-000016.md) | [319](/filings/0001628280-25-050177.md) | [291](/filings/0001628280-26-054328.md) | [275](/filings/0001628280-26-033451.md) | [303](/filings/0001628280-26-054328.md) |
| Total assets | $m | [305](/filings/0001137091-23-000017.md) | [284](/filings/0001137091-25-000005.md) | [287](/filings/0001137091-24-000014.md) | [308](/filings/0001137091-24-000020.md) | [339](/filings/0001137091-24-000027.md) | [328](/filings/0001628280-26-013207.md) | [373](/filings/0001137091-25-000010.md) | [438](/filings/0001137091-25-000016.md) | [459](/filings/0001628280-25-050177.md) | [425](/filings/0001628280-26-054328.md) | [431](/filings/0001628280-26-033451.md) | [453](/filings/0001628280-26-054328.md) |
| Current liabilities | $m | [276](/filings/0001137091-23-000017.md) | [248](/filings/0001137091-25-000005.md) | [246](/filings/0001137091-24-000014.md) | [244](/filings/0001137091-24-000020.md) | [259](/filings/0001137091-24-000027.md) | [228](/filings/0001628280-26-013207.md) | [240](/filings/0001137091-25-000010.md) | [247](/filings/0001137091-25-000016.md) | [140](/filings/0001628280-25-050177.md) | [92.3](/filings/0001628280-26-054328.md) | [80.4](/filings/0001628280-26-033451.md) | [118](/filings/0001628280-26-054328.md) |
| Total liabilities | $m | [318](/filings/0001137091-23-000017.md) | [288](/filings/0001137091-25-000005.md) | [284](/filings/0001137091-24-000014.md) | [283](/filings/0001137091-24-000020.md) | [297](/filings/0001137091-24-000027.md) | [263](/filings/0001628280-26-013207.md) | [288](/filings/0001137091-25-000010.md) | [302](/filings/0001137091-25-000016.md) | [296](/filings/0001628280-25-050177.md) | [246](/filings/0001628280-26-054328.md) | [245](/filings/0001628280-26-033451.md) | [250](/filings/0001628280-26-054328.md) |
| Long-term debt | $m | [0.1](/filings/0001137091-23-000017.md) | [0.1](/filings/0001137091-25-000005.md) | [0.1](/filings/0001137091-24-000014.md) | [0.1](/filings/0001137091-24-000020.md) | [0.1](/filings/0001137091-24-000027.md) | [0.0](/filings/0001628280-26-013207.md) | [0.0](/filings/0001137091-25-000010.md) | [0.0](/filings/0001137091-25-000016.md) | [0.0](/filings/0001628280-25-050177.md) | [0.0](/filings/0001628280-26-054328.md) | [5.1](/filings/0001628280-26-033451.md) | [4.8](/filings/0001628280-26-054328.md) |
| Current portion of debt | $m | [0.1](/filings/0001137091-23-000017.md) | [0.1](/filings/0001137091-25-000005.md) | [0.1](/filings/0001137091-24-000014.md) | [0.1](/filings/0001137091-24-000020.md) | [0.1](/filings/0001137091-24-000027.md) | [0.1](/filings/0001628280-26-013207.md) | [0.1](/filings/0001137091-25-000010.md) | [0.0](/filings/0001137091-25-000016.md) | [0.0](/filings/0001628280-25-050177.md) | [0.0](/filings/0001628280-26-054328.md) | [1.8](/filings/0001628280-26-033451.md) | [0.9](/filings/0001628280-26-054328.md) |
| Short-term borrowings | $m | [160](/filings/0001137091-23-000017.md) | [145](/filings/0001137091-25-000005.md) | [140](/filings/0001137091-24-000014.md) | [135](/filings/0001137091-24-000020.md) | [135](/filings/0001137091-24-000027.md) | [120](/filings/0001628280-26-013207.md) | [110](/filings/0001137091-25-000010.md) | [95.0](/filings/0001137091-25-000016.md) | [0.0](/filings/0001628280-25-050177.md) | [0.0](/filings/0001628280-26-013207.md) | not reported | not reported |
| Shareholders' equity | $m | [(12.3)](/filings/0001137091-24-000027.md) | [(3.9)](/filings/0001628280-26-013207.md) | [3.2](/filings/0001137091-25-000016.md) | [24.8](/filings/0001628280-25-050177.md) | [42.1](/filings/0001628280-25-050177.md) | [65.3](/filings/0001628280-26-054328.md) | [84.3](/filings/0001628280-26-054328.md) | [136](/filings/0001628280-26-054328.md) | [162](/filings/0001628280-25-050177.md) | [179](/filings/0001628280-26-054328.md) | [186](/filings/0001628280-26-054328.md) | [203](/filings/0001628280-26-054328.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: us-gaap:ShortTermBorrowings
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [35.5 d](/filings/0001137091-24-000027.md) | [8.4 d](/filings/0001137091-25-000005.md) | [15.6](/filings/0001137091-25-000010.md) | [1.5 d](/filings/0001137091-25-000016.md) | [12.6 d](/filings/0001628280-25-050177.md) | [32.7 d](/filings/0001628280-26-013207.md) | [8.8](/filings/0001628280-26-033451.md) | [16.7 d](/filings/0001628280-26-054328.md) | [3.3 d](/filings/0001628280-25-050177.md) | [(4.6) d](/filings/0001628280-26-013207.md) | [19.1](/filings/0001628280-26-033451.md) | [56.6 d](/filings/0001628280-26-054328.md) |
| Capital expenditure | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: not reported

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [23.0](/filings/0001137091-23-000017.md) | [23.0](/filings/0001137091-24-000014.md) | [23.0](/filings/0001137091-24-000020.md) | [23.0](/filings/0001137091-24-000027.md) | [23.0](/filings/0001137091-25-000010.md) | [23.0](/filings/0001137091-25-000016.md) | [23.0](/filings/0001628280-25-050177.md) | [23.1](/filings/0001628280-26-033451.md) | [23.1](/filings/0001628280-26-054328.md) | [23.1](/filings/0001628280-25-050177.md) | [23.1](/filings/0001628280-26-033451.md) | [23.1](/filings/0001628280-26-054328.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 23,065,450 at 2026-07-30, from the cover of the [10-Q filed 2026-08-06](/filings/0001628280-26-054328.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:34 ET. No prices; not investment advice.